Safety and Efficacy of PG102P for Uremic Pruritus in HD Patients

NCT03576235 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Uremic Pruritus

Interventions

DRUG: PG102P
DRUG: Placebo

Sponsor

Seoul National University Boramae Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]